ACMR — ACM Research Income Statement
0.000.00%
Last trade - 00:00
- $1.05bn
- $991.86m
- $557.72m
- 71
- 87
- 66
- 87
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 108 | 157 | 260 | 389 | 558 |
Cost of Revenue | |||||
Gross Profit | 50.7 | 69.6 | 115 | 184 | 276 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 89.7 | 135 | 221 | 330 | 462 |
Operating Profit | 17.8 | 21.5 | 38.7 | 59 | 95.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 18.9 | 19.3 | 43.1 | 67.4 | 116 |
Provision for Income Taxes | |||||
Net Income After Taxes | 19.5 | 21.7 | 42.9 | 50.6 | 96.9 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 18.9 | 18.8 | 37.8 | 39.3 | 77.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 18.9 | 18.8 | 37.8 | 39.3 | 77.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.329 | 0.296 | 0.578 | 0.601 | 1.19 |